{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:19Z","timestamp":1787020639170,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302908"],"award-info":[{"award-number":["82302908"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273019"],"award-info":[{"award-number":["82273019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972354,82172901,82472643"],"award-info":[{"award-number":["81972354,82172901,82472643"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172903"],"award-info":[{"award-number":["82172903"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872061"],"award-info":[{"award-number":["81872061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Tianjin Natural Science Foundation","doi-asserted-by":"crossref","award":["22JCYBJC00280"],"award-info":[{"award-number":["22JCYBJC00280"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Outstanding Youth Foundation of Tianjin Medical University General Hospital","award":["22ZYYYQ01"],"award-info":[{"award-number":["22ZYYYQ01"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["(TJYXZDXK-061B)TJLCMS2021-03"],"award-info":[{"award-number":["(TJYXZDXK-061B)TJLCMS2021-03"]}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project","award":["No. TJWJ2023QN063"],"award-info":[{"award-number":["No. TJWJ2023QN063"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06202-1","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T13:03:07Z","timestamp":1739538187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["ZNRF2 is essential for gliomagenesis through orchestrating glycolysis and acts as a promising therapeutic target in glioma"],"prefix":"10.1186","volume":"23","author":[{"given":"Yunlan","family":"Xi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6644-5625","authenticated-orcid":false,"given":"Xuexia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"issue":"6","key":"6202_CR1","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1158\/0008-5472.CAN-23-0024","volume":"83","author":"DB Zamler","year":"2023","unstructured":"Zamler DB, Hu J. Primitive oligodendrocyte precursor cells are highly susceptible to Gliomagenic Transformation. Cancer Res. 2023;83(6):807\u20138.","journal-title":"Cancer Res"},{"issue":"9","key":"6202_CR2","doi-asserted-by":"publisher","first-page":"1902971","DOI":"10.1002\/advs.201902971","volume":"7","author":"B Delgado-Mart\u00edn","year":"2020","unstructured":"Delgado-Mart\u00edn B, Medina M. Advances in the knowledge of the Molecular Biology of Glioblastoma and its impact in patient diagnosis, stratification, and treatment. Adv Sci (Weinh). 2020;7(9):1902971.","journal-title":"Adv Sci (Weinh)"},{"key":"6202_CR3","doi-asserted-by":"crossref","unstructured":"Kaina B, Beltzig L, Piee-Staffa A, Haas B. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells. Int J Mol Sci. 2020; 21(19).","DOI":"10.3390\/ijms21197006"},{"issue":"3","key":"6202_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/cns.13197","volume":"26","author":"J Wang","year":"2020","unstructured":"Wang J, Zuo J, Wahafu A, Wang MD, Li RC, Xie WF. Combined elevation of TRIB2 and MAP3K1 indicates poor prognosis and chemoresistance to temozolomide in glioblastoma. CNS Neurosci Ther. 2020;26(3):297\u2013308.","journal-title":"CNS Neurosci Ther"},{"issue":"11","key":"6202_CR5","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1093\/neuonc\/noz107","volume":"21","author":"Y Sang","year":"2019","unstructured":"Sang Y, Hou Y, Cheng R, Zheng L, Alvarez AA, Hu B, Cheng SY, Zhang W, Li Y, Feng H. Targeting PDGFR\u03b1-activated glioblastoma through specific inhibition of SHP-2-mediated signaling. Neuro Oncol. 2019;21(11):1423\u201335.","journal-title":"Neuro Oncol"},{"issue":"6","key":"6202_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1021\/acs.jproteome.0c00243","volume":"19","author":"J Jothi","year":"2020","unstructured":"Jothi J, Janardhanam VA, Krishnaswamy R. Metabolic variations between low-Grade and High-Grade Gliomas-Profiling by (1)H NMR spectroscopy. J Proteome Res. 2020;19(6):2483\u201390.","journal-title":"J Proteome Res"},{"issue":"7","key":"6202_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.biocel.2010.08.009","volume":"43","author":"AM Weljie","year":"2011","unstructured":"Weljie AM, Jirik FR. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect. Int J Biochem Cell Biol. 2011;43(7):981\u20139.","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"6202_CR8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"key":"6202_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.semcancer.2017.12.011","volume":"56","author":"A Poff","year":"2019","unstructured":"Poff A, Koutnik AP, Egan KM, Sahebjam S, D\u2019Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: ketogenic diets for management of glioma. Semin Cancer Biol. 2019;56:135\u201348.","journal-title":"Semin Cancer Biol"},{"key":"6202_CR10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1476-4598-12-152","volume":"12","author":"S Ganapathy-Kanniappan","year":"2013","unstructured":"Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.","journal-title":"Mol Cancer"},{"issue":"28","key":"6202_CR11","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1523\/JNEUROSCI.23-28-09385.2003","volume":"23","author":"T Araki","year":"2003","unstructured":"Araki T, Milbrandt J. ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases. J Neurosci. 2003;23(28):9385\u201394.","journal-title":"J Neurosci"},{"issue":"21","key":"6202_CR12","doi-asserted-by":"publisher","first-page":"3296","DOI":"10.1111\/jcmm.17900","volume":"27","author":"F Shi","year":"2023","unstructured":"Shi F, Wu Y, Wang K, Wang J, Liu M, Sun X. A pancancer analysis of the oncogenic role of ZNRF2 in human tumours. J Cell Mol Med. 2023;27(21):3296\u2013312.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"6202_CR13","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s13577-023-00913-7","volume":"36","author":"JT Liu","year":"2023","unstructured":"Liu JT, Sun ZX, Zhong R, Zhang YD, Wang T, Hou YD, Bao JH, Zhang L, Chen B. ZNRF2 as an oncogene is transcriptionally regulated by CREB1 in breast cancer models. Hum Cell. 2023;36(4):1501\u201315.","journal-title":"Hum Cell"},{"issue":"19","key":"6202_CR14","first-page":"4011","volume":"20","author":"XF Zhang","year":"2016","unstructured":"Zhang XF, Guo ZQ, Zhao CC, Xu CY, Han M, Li C, Wang Z. The role of ZNRF2 in the growth of non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2016;20(19):4011\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6202_CR15","doi-asserted-by":"crossref","unstructured":"Hoxhaj G, Caddye E, Najafov A, Houde VP, Johnson C, Dissanayake K, Toth R, Campbell DG, Prescott AR, MacKintosh C. The E3 ubiquitin ligase ZNRF2 is a substrate of mTORC1 and regulates its activation by amino acids. Elife. 2016; 5.","DOI":"10.7554\/eLife.12278"},{"issue":"Pt 19","key":"6202_CR16","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1242\/jcs.110296","volume":"125","author":"G Hoxhaj","year":"2012","unstructured":"Hoxhaj G, Najafov A, Toth R, Campbell DG, Prescott AR, MacKintosh C. ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+\/K\u2009+\u2009ATPase. J Cell Sci. 2012;125(Pt 19):4662\u201375.","journal-title":"J Cell Sci"},{"key":"6202_CR17","doi-asserted-by":"publisher","first-page":"113759","DOI":"10.1016\/j.expneurol.2021.113759","volume":"342","author":"C Gu","year":"2021","unstructured":"Gu C, Yang J, Luo Y, Ran D, Tan X, Xiang P, Fei H, Lu Y, Guo W, Tu Y, et al. ZNRF2 attenuates focal cerebral ischemia\/reperfusion injury in rats by inhibiting mTORC1-mediated autophagy. Exp Neurol. 2021;342:113759.","journal-title":"Exp Neurol"},{"issue":"1","key":"6202_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","volume":"19","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al. Chinese Glioma Genome Atlas (CGGA): a Comprehensive Resource with functional genomic data from Chinese glioma patients. Genomics Proteom Bioinf. 2021;19(1):1\u201312.","journal-title":"Genomics Proteom Bioinf"},{"issue":"3","key":"6202_CR19","doi-asserted-by":"publisher","first-page":"2001960","DOI":"10.1002\/advs.202001960","volume":"8","author":"D Hua","year":"2021","unstructured":"Hua D, Tang L, Wang W, Tang S, Yu L, Zhou X, Wang Q, Sun C, Shi C, Luo W, et al. Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a cell-penetrative MMP-2-Cleavable peptide. Adv Sci (Weinh). 2021;8(3):2001960.","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"6202_CR20","doi-asserted-by":"publisher","first-page":"e25643","DOI":"10.1016\/j.heliyon.2024.e25643","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, Sun K, Yang H, Zou D, Xia L, Lu K, Meng X, Li Y. Molecular subtype identification and prognosis stratification based on lysosome-related genes in breast cancer. Heliyon. 2024;10(4):e25643.","journal-title":"Heliyon"},{"issue":"3","key":"6202_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7150\/jca.89581","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Zeng Y, He L, Xie X. Exploring Prognostic Immune Microenvironment-related genes in Head and Neck squamous cell carcinoma from the TCGA database. J Cancer. 2024;15(3):632\u201344.","journal-title":"J Cancer"},{"key":"6202_CR22","doi-asserted-by":"publisher","first-page":"122392","DOI":"10.1016\/j.lfs.2023.122392","volume":"338","author":"W An","year":"2024","unstructured":"An W, Yang Q, Xi Y, Pan H, Huang H, Chen Q, Wang Y, Hua D, Shi C, Wang Q, et al. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma. Life Sci. 2024;338:122392.","journal-title":"Life Sci"},{"key":"6202_CR23","doi-asserted-by":"publisher","first-page":"849592","DOI":"10.3389\/fimmu.2022.849592","volume":"13","author":"C Wei","year":"2022","unstructured":"Wei C, Wang B, Peng D, Zhang X, Li Z, Luo L, He Y, Liang H, Du X, Li S, et al. Pan-cancer Analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple Cancer types including gliomas. Front Immunol. 2022;13:849592.","journal-title":"Front Immunol"},{"issue":"6","key":"6202_CR24","doi-asserted-by":"publisher","first-page":"188988","DOI":"10.1016\/j.bbcan.2023.188988","volume":"1878","author":"H Kang","year":"2023","unstructured":"Kang H, Kim B, Park J, Youn H, Youn B. The Warburg effect on radioresistance: Survival beyond growth. Biochim Biophys Acta Rev Cancer. 2023;1878(6):188988.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"6202_CR25","doi-asserted-by":"publisher","first-page":"188616","DOI":"10.1016\/j.bbcan.2021.188616","volume":"1876","author":"MS Tomar","year":"2021","unstructured":"Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021;1876(2):188616.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"6202_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"6202_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41575-021-00568-5","volume":"19","author":"D Geh","year":"2022","unstructured":"Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2022;19(4):257\u201373.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8000","key":"6202_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","volume":"626","author":"E Vivier","year":"2024","unstructured":"Vivier E, Rebuffet L, Narni-Mancinelli E, Cornen S, Igarashi RY, Fantin VR. Natural killer cell therapies. Nature. 2024;626(8000):727\u201336.","journal-title":"Nature"},{"issue":"5930","key":"6202_CR29","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"29","key":"6202_CR30","doi-asserted-by":"publisher","first-page":"e2400502","DOI":"10.1002\/adma.202400502","volume":"36","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ma H, Li L, Sun C, Yu C, Wang L, Xu D, Song X, Yu R. Dual-targeted Novel Temozolomide Nanocapsules encapsulating siPKM2 inhibit aerobic glycolysis to sensitize Glioblastoma to Chemotherapy. Adv Mater. 2024;36(29):e2400502.","journal-title":"Adv Mater"},{"issue":"4","key":"6202_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1136\/ard.49.4.265","volume":"49","author":"MD Smith","year":"1990","unstructured":"Smith MD, Ahern MJ, Roberts-Thomson PJ. Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis. 1990;49(4):265\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"6202_CR32","first-page":"121","volume":"67","author":"SB Green","year":"1983","unstructured":"Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E Jr., Batzdorf U, Brooks WH, Hunt WE, Mealey J Jr., Odom GL, et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983;67(2):121\u201332.","journal-title":"Cancer Treat Rep"},{"issue":"24","key":"6202_CR33","doi-asserted-by":"publisher","first-page":"8768","DOI":"10.1002\/cam4.4374","volume":"10","author":"A Vagos Mata","year":"2021","unstructured":"Vagos Mata A, Espada E, Alves D, Polo B, Costa MJ, Lopes C, Raposo JFL. Chronic lymphocytic leukaemia\/small lymphocytic lymphoma treatment with rituximab and high-dose methylprednisolone, revisited. Cancer Med. 2021;10(24):8768\u201376.","journal-title":"Cancer Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06202-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06202-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T13:03:19Z","timestamp":1739538199000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06202-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6202"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06202-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board approval"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and registration number"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}},{"value":"The authors declare no competing financial interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"185"}}